Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease

[1]  C von Birgelen,et al.  Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. , 1995, The American journal of cardiology.

[2]  M. Leon,et al.  Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. , 1994, The American journal of cardiology.

[3]  D. Baim,et al.  Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. , 1994, The American journal of cardiology.

[4]  D. Baim,et al.  Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty. , 1994, Journal of the American College of Cardiology.

[5]  P. Serruys,et al.  Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty A Multicenter Randomized Double‐Blind Placebo‐Controlled Trial , 1993, Circulation.

[6]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[7]  T G van Leeuwen,et al.  Intraluminal Vapor Bubble Induced by Excimer Laser Pulse Causes Microsecond Arterial Dilation and Invagination Leading to Extensive Wall Damage in the Rabbit , 1993, Circulation.

[8]  RITA-2 trial participants.  Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[9]  J. Tijssen,et al.  Excimer laser coronary angioplasty in The Netherlands: preamble for a randomized study. , 1993, American heart journal.

[10]  S. Ellis,et al.  Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. , 1992, The American journal of cardiology.

[11]  H. Crijns,et al.  IMPROVEMENT OF PERIPHERAL-BLOOD FLOW AFTER CARDIOVERSION OF ATRIAL-FIBRILLATION , 1992 .

[12]  J. Bittl,et al.  Excimer Laser‐Facilitated Coronary Angioplasty: Relative Risk Analysis of Acute and Follow‐up Results in 200 Patients , 1992, Circulation.

[13]  T G van Leeuwen,et al.  Origin of arterial wall dissections induced by pulsed excimer and mid-infrared laser ablation in the pig. , 1992, Journal of the American College of Cardiology.

[14]  M. Leon,et al.  Excimer Laser Coronary Angioplasty of Aorto‐Ostial Stenoses Results of the Excimer Laser Coronary Angioplasty (ELCA) Registry in the First 200 Patients , 1992, The American journal of cardiology.

[15]  P. Serruys,et al.  Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty With Thromboxane A2‐Receptor Blockade: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 1991, Circulation.

[16]  L. Klein,et al.  Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[17]  E J Topol,et al.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.

[18]  G. Stone,et al.  Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients. , 1990, Journal of the American College of Cardiology.

[19]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[20]  M A Konstam,et al.  The excimer laser: gross, light microscopic and ultrastructural analysis of potential advantages for use in laser therapy of cardiovascular disease. , 1985, Journal of the American College of Cardiology.

[21]  W S Grundfest,et al.  Pulsed ultraviolet lasers and the potential for safe laser angioplasty. , 1985, American journal of surgery.

[22]  W S Grundfest,et al.  Laser ablation of human atherosclerotic plaque without adjacent tissue injury. , 1985, Journal of the American College of Cardiology.

[23]  S. Kelsey,et al.  Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry , 1983, Circulation.

[24]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.

[25]  A. Baumbach,et al.  Formation of pressure waves during in vitro excimer laser irradiation in whole blood and the effect of dilution with contrast media and saline , 1994, Lasers in surgery and medicine.

[26]  H. Oswald,et al.  Clinical results of coronary excimer laser angioplasty: report from the European Coronary Excimer Laser Angioplasty Registry. , 1994, European heart journal.

[27]  P. Serruys,et al.  Quantitative Coronary Angiography in Clinical Practice , 1994, Developments in Cardiovascular Medicine.

[28]  D. Krauthamer.  Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators , 1994 .

[29]  Roland Sauerbrey,et al.  Tissue interactions and measurement of ablation rates with ultraviolet and visible lasers in canine and human arteries , 1987, Lasers in surgery and medicine.

[30]  B. Sakallaris.  Laser therapy for cardiovascular disease. , 1987, Heart & lung : the journal of critical care.

[31]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.